Blinatumomab (trade name Blincyto) is a biopharmaceutical drug used as a second-line treatment for Philadelphia chromosome-negative relapsed or refractory acute lymphoblastic leukemia.
This report aims to provide a comprehensive presentation of the global market for Blinatumomab Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blinatumomab Drugs. This report contains market size and forecasts of Blinatumomab Drugs in global, including the following market information:
Global Blinatumomab Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Blinatumomab Drugs Market Sales, 2018-2023, 2024-2030, (K Units)
Global top five Blinatumomab Drugs companies in 2022 (%)
The global Blinatumomab Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Prefilled Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Blinatumomab Drugs include Amgen. etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Blinatumomab Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Blinatumomab Drugs Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Blinatumomab Drugs Market Segment Percentages, by Type, 2022 (%)
Prefilled
Non-prefilled
Global Blinatumomab Drugs Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Blinatumomab Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Pharmacy
Global Blinatumomab Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Blinatumomab Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Blinatumomab Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Blinatumomab Drugs revenues share in global market, 2022 (%)
Key companies Blinatumomab Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Blinatumomab Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen
Outline of Major Chapters:
Chapter 1: Introduces the definition of Blinatumomab Drugs, market overview.
Chapter 2: Global Blinatumomab Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Blinatumomab Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Blinatumomab Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Blinatumomab Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Blinatumomab Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Blinatumomab Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Blinatumomab Drugs Overall Market Size
2.1 Global Blinatumomab Drugs Market Size: 2022 VS 2030
2.2 Global Blinatumomab Drugs Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Blinatumomab Drugs Sales: 2018-2030
3 Company Landscape
3.1 Top Blinatumomab Drugs Players in Global Market
3.2 Top Global Blinatumomab Drugs Companies Ranked by Revenue
3.3 Global Blinatumomab Drugs Revenue by Companies
3.4 Global Blinatumomab Drugs Sales by Companies
3.5 Global Blinatumomab Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Blinatumomab Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Blinatumomab Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Blinatumomab Drugs Players in Global Market
3.8.1 List of Global Tier 1 Blinatumomab Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Blinatumomab Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Blinatumomab Drugs Market Size Markets, 2022 & 2030
4.1.2 Prefilled
4.1.3 Non-prefilled
4.2 By Type - Global Blinatumomab Drugs Revenue & Forecasts
4.2.1 By Type - Global Blinatumomab Drugs Revenue, 2018-2023
4.2.2 By Type - Global Blinatumomab Drugs Revenue, 2024-2030
4.2.3 By Type - Global Blinatumomab Drugs Revenue Market Share, 2018-2030
4.3 By Type - Global Blinatumomab Drugs Sales & Forecasts
4.3.1 By Type - Global Blinatumomab Drugs Sales, 2018-2023
4.3.2 By Type - Global Blinatumomab Drugs Sales, 2024-2030
4.3.3 By Type - Global Blinatumomab Drugs Sales Market Share, 2018-2030
4.4 By Type - Global Blinatumomab Drugs Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Blinatumomab Drugs Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Pharmacy
5.2 By Application - Global Blinatumomab Drugs Revenue & Forecasts
5.2.1 By Application - Global Blinatumomab Drugs Revenue, 2018-2023
5.2.2 By Application - Global Blinatumomab Drugs Revenue, 2024-2030
5.2.3 By Application - Global Blinatumomab Drugs Revenue Market Share, 2018-2030
5.3 By Application - Global Blinatumomab Drugs Sales & Forecasts
5.3.1 By Application - Global Blinatumomab Drugs Sales, 2018-2023
5.3.2 By Application - Global Blinatumomab Drugs Sales, 2024-2030
5.3.3 By Application - Global Blinatumomab Drugs Sales Market Share, 2018-2030
5.4 By Application - Global Blinatumomab Drugs Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Blinatumomab Drugs Market Size, 2022 & 2030
6.2 By Region - Global Blinatumomab Drugs Revenue & Forecasts
6.2.1 By Region - Global Blinatumomab Drugs Revenue, 2018-2023
6.2.2 By Region - Global Blinatumomab Drugs Revenue, 2024-2030
6.2.3 By Region - Global Blinatumomab Drugs Revenue Market Share, 2018-2030
6.3 By Region - Global Blinatumomab Drugs Sales & Forecasts
6.3.1 By Region - Global Blinatumomab Drugs Sales, 2018-2023
6.3.2 By Region - Global Blinatumomab Drugs Sales, 2024-2030
6.3.3 By Region - Global Blinatumomab Drugs Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Blinatumomab Drugs Revenue, 2018-2030
6.4.2 By Country - North America Blinatumomab Drugs Sales, 2018-2030
6.4.3 US Blinatumomab Drugs Market Size, 2018-2030
6.4.4 Canada Blinatumomab Drugs Market Size, 2018-2030
6.4.5 Mexico Blinatumomab Drugs Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Blinatumomab Drugs Revenue, 2018-2030
6.5.2 By Country - Europe Blinatumomab Drugs Sales, 2018-2030
6.5.3 Germany Blinatumomab Drugs Market Size, 2018-2030
6.5.4 France Blinatumomab Drugs Market Size, 2018-2030
6.5.5 U.K. Blinatumomab Drugs Market Size, 2018-2030
6.5.6 Italy Blinatumomab Drugs Market Size, 2018-2030
6.5.7 Russia Blinatumomab Drugs Market Size, 2018-2030
6.5.8 Nordic Countries Blinatumomab Drugs Market Size, 2018-2030
6.5.9 Benelux Blinatumomab Drugs Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Blinatumomab Drugs Revenue, 2018-2030
6.6.2 By Region - Asia Blinatumomab Drugs Sales, 2018-2030
6.6.3 China Blinatumomab Drugs Market Size, 2018-2030
6.6.4 Japan Blinatumomab Drugs Market Size, 2018-2030
6.6.5 South Korea Blinatumomab Drugs Market Size, 2018-2030
6.6.6 Southeast Asia Blinatumomab Drugs Market Size, 2018-2030
6.6.7 India Blinatumomab Drugs Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Blinatumomab Drugs Revenue, 2018-2030
6.7.2 By Country - South America Blinatumomab Drugs Sales, 2018-2030
6.7.3 Brazil Blinatumomab Drugs Market Size, 2018-2030
6.7.4 Argentina Blinatumomab Drugs Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Blinatumomab Drugs Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Blinatumomab Drugs Sales, 2018-2030
6.8.3 Turkey Blinatumomab Drugs Market Size, 2018-2030
6.8.4 Israel Blinatumomab Drugs Market Size, 2018-2030
6.8.5 Saudi Arabia Blinatumomab Drugs Market Size, 2018-2030
6.8.6 UAE Blinatumomab Drugs Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Amgen
7.1.1 Amgen Company Summary
7.1.2 Amgen Business Overview
7.1.3 Amgen Blinatumomab Drugs Major Product Offerings
7.1.4 Amgen Blinatumomab Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Amgen Key News & Latest Developments
8 Global Blinatumomab Drugs Production Capacity, Analysis
8.1 Global Blinatumomab Drugs Production Capacity, 2018-2030
8.2 Blinatumomab Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Blinatumomab Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Blinatumomab Drugs Supply Chain Analysis
10.1 Blinatumomab Drugs Industry Value Chain
10.2 Blinatumomab Drugs Upstream Market
10.3 Blinatumomab Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Blinatumomab Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Blinatumomab Drugs in Global Market
Table 2. Top Blinatumomab Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Blinatumomab Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Blinatumomab Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Blinatumomab Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Blinatumomab Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Blinatumomab Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Blinatumomab Drugs Product Type
Table 9. List of Global Tier 1 Blinatumomab Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Blinatumomab Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Blinatumomab Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Blinatumomab Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Blinatumomab Drugs Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Blinatumomab Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Blinatumomab Drugs Sales (K Units), 2024-2030
Table 16. By Application ? Global Blinatumomab Drugs Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Blinatumomab Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Blinatumomab Drugs Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Blinatumomab Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Blinatumomab Drugs Sales (K Units), 2024-2030
Table 21. By Region ? Global Blinatumomab Drugs Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Blinatumomab Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Blinatumomab Drugs Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Blinatumomab Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Blinatumomab Drugs Sales (K Units), 2024-2030
Table 26. By Country - North America Blinatumomab Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Blinatumomab Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Blinatumomab Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Blinatumomab Drugs Sales, (K Units), 2024-2030
Table 30. By Country - Europe Blinatumomab Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Blinatumomab Drugs Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Blinatumomab Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Blinatumomab Drugs Sales, (K Units), 2024-2030
Table 34. By Region - Asia Blinatumomab Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Blinatumomab Drugs Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Blinatumomab Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Blinatumomab Drugs Sales, (K Units), 2024-2030
Table 38. By Country - South America Blinatumomab Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Blinatumomab Drugs Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Blinatumomab Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Blinatumomab Drugs Sales, (K Units), 2024-2030
Table 42. By Country - Middle East & Africa Blinatumomab Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Blinatumomab Drugs Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Blinatumomab Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Blinatumomab Drugs Sales, (K Units), 2024-2030
Table 46. Amgen Company Summary
Table 47. Amgen Blinatumomab Drugs Product Offerings
Table 48. Amgen Blinatumomab Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Amgen Key News & Latest Developments
Table 50. Blinatumomab Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 51. Global Blinatumomab Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 52. Global Blinatumomab Drugs Production by Region, 2018-2023 (K Units)
Table 53. Global Blinatumomab Drugs Production by Region, 2024-2030 (K Units)
Table 54. Blinatumomab Drugs Market Opportunities & Trends in Global Market
Table 55. Blinatumomab Drugs Market Drivers in Global Market
Table 56. Blinatumomab Drugs Market Restraints in Global Market
Table 57. Blinatumomab Drugs Raw Materials
Table 58. Blinatumomab Drugs Raw Materials Suppliers in Global Market
Table 59. Typical Blinatumomab Drugs Downstream
Table 60. Blinatumomab Drugs Downstream Clients in Global Market
Table 61. Blinatumomab Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Blinatumomab Drugs Segment by Type in 2022
Figure 2. Blinatumomab Drugs Segment by Application in 2022
Figure 3. Global Blinatumomab Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Blinatumomab Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Blinatumomab Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. Blinatumomab Drugs Sales in Global Market: 2018-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Blinatumomab Drugs Revenue in 2022
Figure 9. By Type - Global Blinatumomab Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Blinatumomab Drugs Revenue Market Share, 2018-2030
Figure 11. By Type - Global Blinatumomab Drugs Sales Market Share, 2018-2030
Figure 12. By Type - Global Blinatumomab Drugs Price (USD/Unit), 2018-2030
Figure 13. By Application - Global Blinatumomab Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Blinatumomab Drugs Revenue Market Share, 2018-2030
Figure 15. By Application - Global Blinatumomab Drugs Sales Market Share, 2018-2030
Figure 16. By Application - Global Blinatumomab Drugs Price (USD/Unit), 2018-2030
Figure 17. By Region - Global Blinatumomab Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Blinatumomab Drugs Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Blinatumomab Drugs Revenue Market Share, 2018-2030
Figure 20. By Region - Global Blinatumomab Drugs Sales Market Share, 2018-2030
Figure 21. By Country - North America Blinatumomab Drugs Revenue Market Share, 2018-2030
Figure 22. By Country - North America Blinatumomab Drugs Sales Market Share, 2018-2030
Figure 23. US Blinatumomab Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Blinatumomab Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Blinatumomab Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Blinatumomab Drugs Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Blinatumomab Drugs Sales Market Share, 2018-2030
Figure 28. Germany Blinatumomab Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. France Blinatumomab Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Blinatumomab Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Blinatumomab Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Blinatumomab Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Blinatumomab Drugs Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Blinatumomab Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Blinatumomab Drugs Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Blinatumomab Drugs Sales Market Share, 2018-2030
Figure 37. China Blinatumomab Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Blinatumomab Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Blinatumomab Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Blinatumomab Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. India Blinatumomab Drugs Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Blinatumomab Drugs Revenue Market Share, 2018-2030
Figure 43. By Country - South America Blinatumomab Drugs Sales Market Share, 2018-2030
Figure 44. Brazil Blinatumomab Drugs Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Blinatumomab Drugs Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Blinatumomab Drugs Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Blinatumomab Drugs Sales Market Share, 2018-2030
Figure 48. Turkey Blinatumomab Drugs Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Blinatumomab Drugs Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Blinatumomab Drugs Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Blinatumomab Drugs Revenue, (US$, Mn), 2018-2030
Figure 52. Global Blinatumomab Drugs Production Capacity (K Units), 2018-2030
Figure 53. The Percentage of Production Blinatumomab Drugs by Region, 2022 VS 2030
Figure 54. Blinatumomab Drugs Industry Value Chain
Figure 55. Marketing Channels
